News
A shortened, all-oral drug regimen worked well for some patients with pre-extensively drug-resistant tuberculosis (pre-XDR TB ...
A meta-analysis of 187 trials shows that Paxlovid and remdesivir reduce the risk for hospitalization in patients with mild-to ...
Journalists covering COVID-19 faced an extraordinarily challenging task of keeping the public informed in a hyper-politicized climate filled with misinformation and reliance on unsubstantiated ...
Hydroxychloroquine and chloroquine have been at the center of debate in recent weeks over which drugs should be used to treat COVID-19. Neither product has strong evidence to support use for this ...
Moderna’s Covid-19 vaccine showed 93% efficacy against symptomatic disease through six months, and the company expects to complete its application for full approval from the US Food and Drug ...
Medicines designed to treat COVID-19 won't be available for months, so doctors are looking to drugs already approved for treating other diseases.
This Sunday, 60 Minutes reports on how a 40-year-old obsessive-compulsive disorder drug, Fluvoxamine, is being tested in the U.S. and Canada to be repurposed and possibly used in the fight against ...
A triple combination of interferon beta-1b, lopinavir-ritonavir, and ribavirin may significantly reduce symptoms of COVID-19 and SARS-CoV-2 shedding.
The global effort to develop a coronavirus disease 2019 (COVID-19) vaccine is on track to produce one or more authorized vaccines. We examine how different definitions and thresholds of vaccine ...
CureVac (5CV.DE) said its COVID-19 vaccine was 48% effective in the final analysis of its pivotal mass trial, only marginally better than the 47% reported after an initial read-out two weeks ago.
The same team of Estonian- and Norwegian-based researchers set out to test the efficacy of convalescent blood plasma for treating COVID-19, after concerns emerged that the approach may not be as ...
Researchers evaluated the efficacy of small molecule drugs against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in vitro.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results